Citizens analyst Jonathan Wolleben reiterated a Market Outperform rating and $4.00 price target on Skye Bioscience (NASDAQ: SKYE).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE